Kyra de Miroschedji is a certified biologist and a shareholder of the biotech start-up Lysatpharma GmbH. She completed her studies focusing on molecular and developmental biology at Heinrich-Heine Düsseldorf University. Subsequently, she worked in stem-cell research. As a certified quality auditor, she gained experience in the area of quality, project and process management. Her focus at Lysatpharma lies in coordinating the scientific program and developing inventions. Additionally, she does research in the field of immunology and executes preclinical studies at Jena University Hospital.